Gliptins vs. Milk-derived Dipeptidyl-Peptidase IV Inhibiting Biopeptides: Physicochemical Characterization and Pharmacokinetic Profiling

Background: Milk-derived biopeptides have reported in vitro dipeptidyl-peptidase IV (DPP-IV) inhibition, suggesting a glycemic-regulatory effect in Type 2 Diabetes Mellitus (T2DM). Nonetheless, the therapeutic application of these nutraceuticals is limited by the scarcity of knowledge regarding the...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Jorge Andrés Barrero, Fabio Cabrera, Claudia Marcela Cruz
Format: article
Langue:EN
Publié: Universidad de Antioquia 2021
Sujets:
Accès en ligne:https://doaj.org/article/b54a861ec7f74571ad98ecd6286ca34c
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!